Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Gross profit as a percentage of revenue
5Y CAGR
-1.0%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 94.87% | -5.1% |
| 2024 | 100.00% | +241.7% |
| 2023 | 29.26% | +224.7% |
| 2022 | -23.46% | +90.6% |
| 2021 | -250.12% | -350.1% |
| 2020 | 100.00% | 0.0% |
| 2019 | 100.00% | +1.2% |
| 2018 | 98.82% | +62.5% |
| 2017 | 60.81% | -35.3% |
| 2016 | 94.05% | - |